Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort
et al., Journal of International Medical Research, doi:10.1177/03000605221090363
Retrospective RA/SLE patients in Saudi Arabia. Numbers in this paper are contradictory. Figure 1 and the introduction to the results indicate 304 HCQ users, while Table 1 and later in the results shows 207 (arms switched). The subsequent text reporting the ICU results (2 non-HCQ-users, zero HCQ users) suggests that the labels are switched in Figure 2, or possibly just specific results.
This study is excluded in meta
analysis:
unresolved data inconsistency.
Walbi et al., 6 Apr 2022, retrospective, Saudi Arabia, peer-reviewed, 16 authors, study period March 2020 - February 2021.
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.